La rabia es una zoonosis vírica endémica en el Perú. En el año 1996 ocurrieron dos casos en la población asegurada atendida por el Instituto Peruano de Seguridad Social (IPSS), para una tasa de incidencia de 0.03 por cien mil asegurados. Hasta el mes de octubre del año 1997, se han reportado la ocurrencia de tres casos (tasa de incidencia de 0.04 por cien mil asegurados), procedentes de las Gerencias Departamentales de Pucallpa y Junín. Todos los casos notificados en ambos años fallecieron, por lo que la tasa de letalidad fue de 100%. Este artículo tiene el propósito de contribuir a elevar el nivel de información sobre aspectos clínico-epidemiológicos, de comportamiento y manejo de la rabia humana en el Perú.

Introduction: The Mortality–Incidence Ratio complement [1 – MIR] is an indicator validated in various populations to estimate five-year cancer survival, but its validity remains unreported in Peru. This study aims to determine if the MIR correlates directly with five-year survival in patients diagnosed with the ten most common types of cancer in metropolitan Lima. Materials and methods: The Metropolitan Lima Cancer Registry (RCLM in Spanish) for 2004–2005 was used to determine the number of new cases and the number of deaths of the following cancers: breast, stomach, prostate, thyroid, lung, colon, cervical, and liver cancers, as well as non-Hodgkin’s lymphoma and leukaemia. To determine the five-year survival, the five-year vital status of cases recorded was verified in the National Registry of Identification and Civil Status (RENIEC in Spanish). A linear regression model was us...

Peru is a South American nation with a growing and aging population of 31 million people with a life expectancy at birth of 76.7 years. The country is divided into 25 regions, 79% of the population is urban, and Lima, the capital, concentrates more than a third of the population.1 Although Peru is an upper-middle-income country, health expenditure represents only 5.1% of the gross domestic product, which is lower than the average of Latin America and the Caribbean (LATAM) (8.56%).2 Out-of-pocket health expenditure is 30.9%.3 Peru has a comprehensive National Cancer Plan and two population-based cancer registries in Lima and Arequipa.